Jump to content


  • Content Count

  • Joined

  • Last visited

  • Days Won


KatieB last won the day on May 12 2020

KatieB had the most liked content!


About KatieB

  • Rank
    SrVP Survivorship & Support, LUNGevity
  • Birthday May 25

Profile Information

  • City
  • US State (if applicable)
  • Country
  • Gender
  • Status
    Not a patient

Recent Profile Visitors

7,523 profile views
  1. KatieB


  2. KatieB


  3. Orig article here: https://www.healthline.com/health/cancer/chemotherapy-cost#takeaway Chemotherapy, or chemo, is a form of drug therapy that destroys fast-spreading cancer cells. It’s used to treat cancer and reduce symptoms like pain. If you have a cancer diagnosis, your doctor might recommend chemo on its own or with other treatments. In either case, you’ll likely have a lot of questions, including how much chemotherapy will cost. Understandably, navigating these costs can be overwhelming. Any feelings you have are valid. It may help to learn about chemotherapy expenses
  4. REPOSTING: We are looking for patients and caregivers of those who have been diagnosed with Small-Cell Lung Cancer (SCLC) to participate in confidential remote (online/telephone) research. The purpose of the study is to understand the experiences and challenges of those affected by SCLC. The information from this study will be used to increase understanding of the experience and the impact of the condition. The study is open to adult SCLC patients and/or their unpaid caregivers in the USA. Your name and personal information will be held strictly confidential. Compensation
  5. ****(Reposting this information. Please print the attachment if you'd like to discuss with your healthcareprovider) Title: A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 145) in Patients with Metastatic Non-Small-Cell Lung Cancer: IOV-LUN-202 is a clinical study for patients with non-small cell lung cancer that has progressed after a single-line of therapy with chemotherapy + immunotherapy for their metastatic disease. Patients receive LN-145, a highly personalized immunotherapy developed from their own immune cells (tumor infiltrating lymphocyte
  6. ***reposting information about this trial. Please print off the attachments if you would like to discuss this with your healthcare provider) Title: A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (TIL) in Patients with Solid Tumors: IOV-COM-202 is a clinical study for patients with relapsed or refractory metastatic non-small cell lung cancer using LN-145 in combination with checkpoint inhibitors (e.g., Keytruda or Opdivo). LN-145 is a highly personalized immunotherapy, developed from a patient’s own immune cells (tumor infiltrating lymphocytes;
  7. Definitely let the oncologist know. Immunotherapy may have a cumulative effect or it may be completely unrelated. He may order a scan just to be certain and that would give you some peace of mind- not to mention address that side effect. Wishing your mom the best. Please keep us posted!
  8. Reposting this opportunity created by lung cancer survivor and MD, Dr. Morhaf Achkar. "LUNG CANCER AMONG BLACK AMERICANS We invite you to be part of a research study about the lung cancer experiences of Black/African Americans. This study is being conducted by Morhaf Al Achkar and his collaborators. The goal is to understand the racial health disparity related lung cancer diagnosis. Please consider study participation if you are a Black/African American person with lung cancer. Caregivers, healthcare providers and community advocates for Black/African American patie
  9. HI, Please see the information attached on two new trials to discuss with your doctor - Mariposa_PAG Clinical Trial_09Feb21.pdf PapIllon_PAG Clinical Trial 09Feb21.pdf
  10. Pregnancy and Lung Cancer Researchers at the University of Colorado Anschutz Cancer Center are collecting patient experiences related to being diagnosed with and/or treated for lung cancer while pregnant, being diagnosed shortly after giving birth, or considering becoming pregnant while on a TKI. At present oncologists and obstetricians have little data on these topics to offer their patients. Patients need more information to make decisions that balance the relative risks to both lives at stake. If you have had any the experiences mentioned above, you can help yourself and othe
  11. Ph I/II trial evaluating our KRAS G12C inhibitor, MRTX 849 as monotherapy & in combination with other agents in NSCLC and other tumors. https://www.clinicaltrials.gov/ct2/show/NCT03785249 Sapphire study. Ph III comparing sitravatinib+nivolumab vs. docetaxel in NSCLC patients who progressed on prior PD-1/PD-L1 based therapy https://www.clinicaltrials.gov/ct2/show/NCT03906071
  12. The VA Has Embraced Artificial Intelligence To Improve Veterans' Health Care https://www.scpr.org/news/2020/04/17/92010/the-va-has-embraced-artificial-intelligence-to-imp/ Inside a laboratory at the James A. Haley Veterans' Hospital in Tampa, Fla., machines are rapidly processing tubes of patients' body fluids and tissue samples. Pathologists examine those samples under microscopes to spot signs of cancer and other diseases. But distinguishing certain features about a cancer cell can be difficult, so Drs. Stephen Mastorides and Andrew Borkowski, decided to get a computer involve
  13. We need to hear from you!! “Are you worried about your lung cancer treatment and participating in clinical trials during #COVID19? If you live in the United States, please share your concerns with us so we can start to address them.” https://www.surveymonkey.com/r/COVID19_LC_treatment_clinical_trials
  14. its 75 today after some gloomy rainy days... I'm enjoying all the fun jokes and good news I'm seeing online this week. I hope all of you are doing well.
  15. I love this idea! And I love Oxford! I had a beloved Yorkie too (RIP) Here is my furry brood.
  • Create New...